On the mode of action of a new antifungal antibiotic, pyrrolnitrin.
D000327:Adsorption; D000935:Antifungal Agents / Q000494:pharmacology*; D001410:Bacillus megaterium / Q000187:drug effects*; D002175:Candida / Q000187:drug effects*; D002462:Cell Membrane / Q000187:drug effects; D004247:DNA / Q000096:biosynthesis; D010101:Oxygen Consumption; D010743:Phospholipids / Q000502:physiology; D011166:Porphyrins / Q000096:biosynthesis; D014176:Protein Biosynthesis; D011523:Protoplasts / Q000187:drug effects; D012313:RNA / Q000096:biosynthesis; D012241:Rhodopseudomonas / Q000187:drug effects*; D013696:Temperature
D000935:Antifungal Agents; D010743:Phospholipids; D011166:Porphyrins; D012313:RNA; D004247:DNA